Literature DB >> 15827163

Human immunodeficiency virus type 1 inhibits DNA damage-triggered apoptosis by a Nef-independent mechanism.

Michael Schindler1, Jan Münch, Frank Kirchhoff.   

Abstract

It is controversial whether the accessory human immunodeficiency virus type 1 (HIV-1) Nef protein inhibits or enhances apoptosis. To address this issue, we investigated the effect of Nef on programmed cell death with vectors or proviral HIV-1 constructs coexpressing Nef and green fluorescent protein from single bicistronic RNAs. This approach allows us to readily identify transfected or infected cells and to correlate cell death directly with Nef expression levels. We demonstrate that Nef does not significantly affect apoptosis in transfected or HIV-1-infected Jurkat T cells or primary human peripheral blood mononuclear cells. Unexpectedly, however, both nef+ and nef-defective HIV-1 infection blocked apoptosis in cells treated with UV light or etoposide but not cell death induced by CD95 antibody, TRAIL, Ly294002, or serum starvation. Our results show that HIV-1 infection inhibits DNA damage-induced but not death receptor-dependent cell death by a Nef-independent mechanism.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15827163      PMCID: PMC1082752          DOI: 10.1128/JVI.79.9.5489-5498.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  51 in total

Review 1.  Nef: agent of cell subversion.

Authors:  Vivek K Arora; Brenda L Fredericksen; J Victor Garcia
Journal:  Microbes Infect       Date:  2002-02       Impact factor: 2.700

2.  CD4+ T-cell depletion in HIV infection: are we closer to understanding the cause?

Authors:  Zvi Grossman; Martin Meier-Schellersheim; Ana E Sousa; Rui M M Victorino; William E Paul
Journal:  Nat Med       Date:  2002-04       Impact factor: 53.440

Review 3.  Apoptosis as an HIV strategy to escape immune attack.

Authors:  Marie-Lise Gougeon
Journal:  Nat Rev Immunol       Date:  2003-05       Impact factor: 53.106

4.  Human immunodeficiency virus type 1 Nef binds to tumor suppressor p53 and protects cells against p53-mediated apoptosis.

Authors:  Alison L Greenway; Dale A McPhee; Kelly Allen; Ricky Johnstone; Gavan Holloway; John Mills; Ahmed Azad; Sonia Sankovich; Paul Lambert
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

5.  The course of etoposide-induced apoptosis from damage to DNA and p53 activation to mitochondrial release of cytochrome c.

Authors:  Natalie O Karpinich; Marco Tafani; Ronald J Rothman; Matteo A Russo; John L Farber
Journal:  J Biol Chem       Date:  2002-02-25       Impact factor: 5.157

6.  Down-modulation of mature major histocompatibility complex class II and up-regulation of invariant chain cell surface expression are well-conserved functions of human and simian immunodeficiency virus nef alleles.

Authors:  Michael Schindler; Stephanie Würfl; Philippe Benaroch; Thomas C Greenough; Rod Daniels; Philippa Easterbrook; Matthias Brenner; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

7.  Induction of cell death in human immunodeficiency virus-infected macrophages and resting memory CD4 T cells by TRAIL/Apo2l.

Authors:  J J Lum; A A Pilon; J Sanchez-Dardon; B N Phenix; J E Kim; J Mihowich; K Jamison; N Hawley-Foss; D H Lynch; A D Badley
Journal:  J Virol       Date:  2001-11       Impact factor: 5.103

8.  Highly pathogenic simian immunodeficiency virus mne variants that emerge during the course of infection evolve enhanced infectivity and the ability to downregulate CD4 but not class I major histocompatibility complex antigens.

Authors:  Parul G Patel; Monica T Yu Kimata; Julia E Biggins; Joelle M Wilson; Jason T Kimata
Journal:  J Virol       Date:  2002-07       Impact factor: 5.103

Review 9.  Mechanisms of CD4+ T lymphocyte cell death in human immunodeficiency virus infection and AIDS.

Authors:  Judie B Alimonti; T Blake Ball; Keith R Fowke
Journal:  J Gen Virol       Date:  2003-07       Impact factor: 3.891

10.  Nef associates with p21-activated kinase 2 in a p21-GTPase-dependent dynamic activation complex within lipid rafts.

Authors:  Kati Pulkkinen; G Herma Renkema; Frank Kirchhoff; Kalle Saksela
Journal:  J Virol       Date:  2004-12       Impact factor: 5.103

View more
  43 in total

1.  Counteraction of HLA-C-mediated immune control of HIV-1 by Nef.

Authors:  Anke Specht; Amalio Telenti; Raquel Martinez; Jacques Fellay; Elizabeth Bailes; David T Evans; Mary Carrington; Beatrice H Hahn; David B Goldstein; Frank Kirchhoff
Journal:  J Virol       Date:  2010-05-12       Impact factor: 5.103

2.  Contribution of Vpu, Env, and Nef to CD4 down-modulation and resistance of human immunodeficiency virus type 1-infected T cells to superinfection.

Authors:  Steffen Wildum; Michael Schindler; Jan Münch; Frank Kirchhoff
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

3.  Vpu is the main determinant for tetraspanin downregulation in HIV-1-infected cells.

Authors:  Marie Lambelé; Herwig Koppensteiner; Menelaos Symeonides; Nathan H Roy; Jany Chan; Michael Schindler; Markus Thali
Journal:  J Virol       Date:  2015-01-07       Impact factor: 5.103

4.  Productive entry of HIV-1 during cell-to-cell transmission via dynamin-dependent endocytosis.

Authors:  Richard D Sloan; Björn D Kuhl; Thibault Mesplède; Jan Münch; Daniel A Donahue; Mark A Wainberg
Journal:  J Virol       Date:  2013-05-15       Impact factor: 5.103

5.  HIV-1 Nef and Vpu Interfere with L-Selectin (CD62L) Cell Surface Expression To Inhibit Adhesion and Signaling in Infected CD4+ T Lymphocytes.

Authors:  Lia Vassena; Erica Giuliani; Herwig Koppensteiner; Sebastian Bolduan; Michael Schindler; Margherita Doria
Journal:  J Virol       Date:  2015-03-11       Impact factor: 5.103

6.  Mutations in the HIV-1 envelope glycoprotein can broadly rescue blocks at multiple steps in the virus replication cycle.

Authors:  Rachel Van Duyne; Lillian S Kuo; Phuong Pham; Ken Fujii; Eric O Freed
Journal:  Proc Natl Acad Sci U S A       Date:  2019-04-11       Impact factor: 11.205

7.  Efficient Nef-mediated downmodulation of TCR-CD3 and CD28 is associated with high CD4+ T cell counts in viremic HIV-2 infection.

Authors:  Mohammad Khalid; Hangxing Yu; Daniel Sauter; Shariq M Usmani; Jan Schmokel; Jerome Feldman; Rob A Gruters; Marchina E van der Ende; Matthias Geyer; Sarah Rowland-Jones; Albert D Osterhaus; Frank Kirchhoff
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

8.  Comparative proteomic analysis of HIV-1 particles reveals a role for Ezrin and EHD4 in the Nef-dependent increase of virus infectivity.

Authors:  Christelle Brégnard; Alessia Zamborlini; Marjorie Leduc; Philippe Chafey; Luc Camoin; Ali Saïb; Serge Benichou; Olivier Danos; Stéphane Basmaciogullari
Journal:  J Virol       Date:  2013-01-16       Impact factor: 5.103

9.  Tetherin Antagonism by HIV-1 Group M Nef Proteins.

Authors:  Juan F Arias; Marta Colomer-Lluch; Benjamin von Bredow; Justin M Greene; Julie MacDonald; David H O'Connor; Ruth Serra-Moreno; David T Evans
Journal:  J Virol       Date:  2016-11-14       Impact factor: 5.103

10.  Nef-mediated enhancement of virion infectivity and stimulation of viral replication are fundamental properties of primate lentiviruses.

Authors:  Jan Münch; Devi Rajan; Michael Schindler; Anke Specht; Elke Rücker; Francis J Novembre; Eric Nerrienet; Michaela C Müller-Trutwin; Martine Peeters; Beatrice H Hahn; Frank Kirchhoff
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.